PHARMACOKINETICS OF PHENOBARBITAL FOLLOWING SINGLE AND REPEATED DOSES

[1] ASHLEY JJ, 1972, RES COMMUN CHEM PATH, V4, P297

[2] BAHR CV, 1970, ACTA PHARMACOL TO S1, V28, P2

[3] CLINICAL PHARMACOKINETICS OF HYPNOTICS [J]. CLINICAL PHARMACOKINETICS, 1977, 2 (02) : 93 - 109

[4] CONNEY AH, 1967, PHARMACOL REV, V19, P317

[5] JANCHEN E, 1972, P SOC EXP BIOL MED, V141, P963

[6] BIOAVAILABILITY OF ORAL AND INTRAMUSCULAR PHENOBARBITAL [J]. JOURNAL OF CLINICAL PHARMACOLOGY, 1978, 18 (2-3) : 100 - 105

[7] VISWANATHAN CT, 1977, CLIN CHEM, V23, P873

[8] WHYTE MP, 1977, DRUG METAB DISPOS, V5, P63

[1] ASHLEY JJ, 1972, RES COMMUN CHEM PATH, V4, P297

[2] BAHR CV, 1970, ACTA PHARMACOL TO S1, V28, P2

[3] CLINICAL PHARMACOKINETICS OF HYPNOTICS [J]. CLINICAL PHARMACOKINETICS, 1977, 2 (02) : 93 - 109

[4] CONNEY AH, 1967, PHARMACOL REV, V19, P317

[5] JANCHEN E, 1972, P SOC EXP BIOL MED, V141, P963

[6] BIOAVAILABILITY OF ORAL AND INTRAMUSCULAR PHENOBARBITAL [J]. JOURNAL OF CLINICAL PHARMACOLOGY, 1978, 18 (2-3) : 100 - 105

[7] VISWANATHAN CT, 1977, CLIN CHEM, V23, P873

[8] WHYTE MP, 1977, DRUG METAB DISPOS, V5, P63